Koehler VF, Berg E, Adam P, Weber GL, et al. Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer. Thyroid 2021 Aug 18. doi: 10.1089/thy.2021.0091.
PMID: 34405734